About this episode
Generally, patients have to show symptoms of a disease before they’re treated for it. But, increasingly, thanks to advances in precision medicine, some new treatments are focused on the prevention of diseases that people are most at risk for - and that risk is determined by their unique genetic data. While personalized medicine sounds great in principle, there are several challenges, including the cost. Antonio Regalado, senior editor of biomedicine for MIT Technology Review, and Carlos Bustamante, professor of biomedical data science, genetics, and biology at Stanford, talk to us about the past, present, and future of genetic data in health care.
Get every episode summarized
Each time Innovation Hub publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
